01
Strategy & feasibility
Protocol review, country and site strategy, operational feasibility, and enrollment planning.
Clinical research organization
Clinical research, managed with clarity.
Flexible clinical research support for biotech and pharmaceutical sponsors—built around clear ownership, senior attention, and visible decisions.
Focused teams Flexible delivery Transparent governance
Integrated capabilities
Support across the clinical research lifecycle
Engage one integrated team or select the functions your program needs most.
02
Study start-up
Regulatory coordination, essential documents, site activation, and readiness tracking.
03
Clinical operations
Project leadership, monitoring, site management, vendor coordination, and escalation.
04
Data, safety & quality
Data coordination, safety oversight, TMF controls, risk management, and inspection readiness.
Closeout & readinessReconciliation, site closeout, and inspection readiness.
A sharper line of sight
A right-sized CRO model keeps decisions close to delivery.
Our approach connects sponsor priorities with daily execution, emerging risks, and the forecast.
- Senior attentionLeadership stays close to execution and sponsor decisions.
- Therapeutic contextOperational choices reflect protocol and indication realities.
- Visible governanceDecisions, owners, due dates, and impact remain clear.
Flexible engagement
01
Full-service
Integrated ownership across agreed study functions.
02
Functional service
Focused capability embedded within sponsor governance.
03
Hybrid / adaptive
Shared ownership that evolves with program needs.
Quality by design
Quality is built into how the study is run.
Critical-to-quality factors become operational controls, review points, and documented decisions—not final-stage cleanup.
01
Define critical data and processes
02
Set owners, thresholds, and cadence
03
Review site, data, and delivery signals
04
Document actions and effectiveness
Therapeutic focus
Prepared for operational complexity
Our team’s therapeutic experience includes oncology, ophthalmology, dermatology, CNS, diabetes, cardiovascular, and vaccines across Phase I–IV clinical trials.
Oncology
Complex protocols, safety oversight, specialized sites, and cross-functional delivery.
Ophthalmology
Specialized assessments, imaging workflows, endpoint execution, and site readiness.
Experienced team
Clinical leadership stays close to the work.
Our team brings hands-on experience across Phase I–IV trials, multiple therapeutic areas, and the full study lifecycle—from feasibility and start-up through clinical operations, monitoring, quality oversight, and closeout.
Sponsor confidence
Experience aligned to every phase
Our team brings experience across Phase I–IV trials, supported by scope-specific planning, qualified resourcing, transparent governance, and quality-focused oversight.
Leadership
Relevant clinical operations, start-up, monitoring, feasibility, and team leadership experience.
Proposed team
Named roles, qualifications, availability, responsibilities, and escalation coverage.
Delivery plan
Scope-specific timelines, assumptions, governance, dependencies, and risk controls.
Quality foundation
SOPs, training, vendor qualification, TMF expectations, and oversight approach.
Next conversation
Define the right first engagement.
A focused discovery conversation can align program stage, scope, ownership, evidence needs, and the path to a tailored proposal.
Sponsors and partners info@aarvap.com
Investigators and research sites investigators@aarvap.com